Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers.

@article{Oser2007OrganizationallevelPO,
  title={Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers.},
  author={Carrie B. Oser and Paul Roman},
  journal={Journal of studies on alcohol and drugs},
  year={2007},
  volume={68 6},
  pages={852-61}
}
OBJECTIVE Prominent on the nation's research agenda on substance-use disorders treatment is the dissemination of effective pharmacotherapies. Thus, the purpose of this article is to use a "diffusion of innovations" theoretical framework to examine the organizationallevel predictors of the adoption of a pharmacotherapy, naltrexone (Revia), in private substance use-disorders treatment centers (N = 165). METHOD Data for these analyses were derived from the National Treatment Center Study, which… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…